Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Goerner's incentive

"any one of the following:"

"the successful closing of a merger or acquisition brought forth primarily due to the efforts of the optionee"

Done. No more incentive.

It also explains his focus on M&A over the core patent.

And there was alway this fallback:

"or approval by the Board of Directors for the partial vesting of the option"

Share
New Message
Please login to post a reply